What is the address of DR DE SELYS LONGCHAMPS , PEDIATRE?

The registered office of DR DE SELYS LONGCHAMPS , PEDIATRE is located at Dodonéestraat 82, 1180 Ukkel.

Is DR DE SELYS LONGCHAMPS , PEDIATRE still active?

Yes. According to the CBE (30 September 2026) DR DE SELYS LONGCHAMPS , PEDIATRE is active, legal situation “Normale toestand”, started on 20 March 2006.

Is DR DE SELYS LONGCHAMPS , PEDIATRE registered on Peppol?

Yes, DR DE SELYS LONGCHAMPS , PEDIATRE is registered on the Peppol network with ID 0208:0880077040.

What is the enterprise number of DR DE SELYS LONGCHAMPS , PEDIATRE?

The enterprise number of DR DE SELYS LONGCHAMPS , PEDIATRE is BE0880077040.

When was DR DE SELYS LONGCHAMPS , PEDIATRE founded?

DR DE SELYS LONGCHAMPS , PEDIATRE was founded on 20 March 2006.

Who are the directors of DR DE SELYS LONGCHAMPS , PEDIATRE?

According to the 2025 annual accounts, the directors of DR DE SELYS LONGCHAMPS , PEDIATRE are: Jean Michel Ariel Baron de SELYS LONGCHAMPS.

Is DR DE SELYS LONGCHAMPS , PEDIATRE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 March 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR DE SELYS LONGCHAMPS , PEDIATRE make in 2025?

DR DE SELYS LONGCHAMPS , PEDIATRE posted a profit after taxes of € 32,676 in financial year 2025.

What is the revenue of DR DE SELYS LONGCHAMPS , PEDIATRE?

As a small company, DR DE SELYS LONGCHAMPS , PEDIATRE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 61,970.

DR DE SELYS LONGCHAMPS , PEDIATRE (Private Limited)

Dossier DR DE SELYS LONGCHAMPS , PEDIATRE, printed on 30 September 2026 from databakkes.be/en/0880077040/dr-de-selys-longchamps-pediatre. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR DE SELYS LONGCHAMPS , PEDIATRE from Ukkel, company number BE0880077040, closed financial year 2025 with a result of € 32,676 after tax. For that financial year DR DE SELYS LONGCHAMPS , PEDIATRE recorded a gross margin of € 61,970 and equity of € 169,409. Compared with financial year 2024, the result moved from € 30,571 to € 32,676. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Growing

€ 169,409

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 32,676

▲ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 9,874

▼ 80% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 20,000 paid out

61 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 15,265

▼ 18% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 6,946

▼ 52% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 16,915

▲ € 16,651 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,260

▼ 74% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 64,810 Gross margin 2022: € 64,810 First fiscal year in the series	€ 3,246 Gross margin 2023: € 3,246 ▼ 95% vs 2022 (€ 64,810) Unfavourable step	€ 48,630 Gross margin 2024: € 48,630 ▲ € 45,384 vs 2023 (€ 3,246) Favourable step	€ 61,970 Gross margin 2025: € 61,970 ▲ 27% vs 2024 (€ 48,630) Favourable step	▲ 27%
Profit after taxes	€ 35,384 Profit after taxes 2022: € 35,384 First fiscal year in the series	€ -11,426 Profit after taxes 2023: € -11,426 ▼ € 46,810 vs 2022 (€ 35,384) Unfavourable step	€ 30,571 Profit after taxes 2024: € 30,571 ▲ € 41,997 vs 2023 (€ -11,426) Favourable step	€ 32,676 Profit after taxes 2025: € 32,676 ▲ 7% vs 2024 (€ 30,571) Favourable step	▲ 7%
Equity	€ 208,587 Equity 2022: € 208,587 First fiscal year in the series	€ 153,162 Equity 2023: € 153,162 ▼ 27% vs 2022 (€ 208,587) Unfavourable step	€ 156,733 Equity 2024: € 156,733 ▲ 2% vs 2023 (€ 153,162) Favourable step	€ 169,409 Equity 2025: € 169,409 ▲ 8% vs 2024 (€ 156,733) Favourable step	▲ 8%
Total debts	€ 53,835 Total debts 2022: € 53,835 First fiscal year in the series	€ 82,340 Total debts 2023: € 82,340 ▲ 53% vs 2022 (€ 53,835) Unfavourable step	€ 58,276 Total debts 2024: € 58,276 ▼ 29% vs 2023 (€ 82,340) Favourable step	€ 53,503 Total debts 2025: € 53,503 ▼ 8% vs 2024 (€ 58,276) Favourable step	▼ 8%
Cash	€ 188,272 Cash 2022: € 188,272 First fiscal year in the series	€ 166,030 Cash 2023: € 166,030 ▼ 12% vs 2022 (€ 188,272) Unfavourable step	€ 50,224 Cash 2024: € 50,224 ▼ 70% vs 2023 (€ 166,030) Unfavourable step	€ 9,874 Cash 2025: € 9,874 ▼ 80% vs 2024 (€ 50,224) Unfavourable step	▼ 80%
Retained profit	€ 188,587 Retained profit 2022: € 188,587 First fiscal year in the series	€ 133,162 Retained profit 2023: € 133,162 ▼ 29% vs 2022 (€ 188,587) Unfavourable step	€ 136,733 Retained profit 2024: € 136,733 ▲ 3% vs 2023 (€ 133,162) Favourable step	€ 149,409 Retained profit 2025: € 149,409 ▲ 9% vs 2024 (€ 136,733) Favourable step	▲ 9%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 44,000 Dividend 2023: € 44,000 Unchanged (€ 0) Unchanged	€ 27,000 Dividend 2024: € 27,000 ▼ 39% vs 2023 (€ 44,000) Unchanged	€ 20,000 Dividend 2025: € 20,000 ▼ 26% vs 2024 (€ 27,000) Unchanged	▼ 26%
Bank debt	€ 29,165 Bank debt 2022: € 29,165 First fiscal year in the series	€ 21,845 Bank debt 2023: € 21,845 ▼ 25% vs 2022 (€ 29,165) Favourable step	€ 14,439 Bank debt 2024: € 14,439 ▼ 34% vs 2023 (€ 21,845) Favourable step	€ 6,946 Bank debt 2025: € 6,946 ▼ 52% vs 2024 (€ 14,439) Favourable step	▼ 52%
Balance sheet total	€ 262,423 Balance sheet total 2022: € 262,423 First fiscal year in the series	€ 235,502 Balance sheet total 2023: € 235,502 ▼ 10% vs 2022 (€ 262,423) Unchanged	€ 215,008 Balance sheet total 2024: € 215,008 ▼ 9% vs 2023 (€ 235,502) Unchanged	€ 222,912 Balance sheet total 2025: € 222,912 ▲ 4% vs 2024 (€ 215,008) Unchanged	▲ 4%

Key figures of DR DE SELYS LONGCHAMPS , PEDIATRE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR DE SELYS LONGCHAMPS , PEDIATRE?

What happened at DR DE SELYS LONGCHAMPS , PEDIATRE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 23, 2026 New annual accounts for financial year 2025: profit of € 32,676 (▲ 7% vs 2024). Source: NBB ↗
Mar 20, 2006 Start of the company according to the CBE. KBO
2006 Jean Michel Ariel Baron de SELYS LONGCHAMPS became a director. NBB

In short

From € 35,384 profit in 2022 to € 32,676 profit in 2025.

Paid € 45,735 in corporate taxes since 2022.

Best year ever: 2022, with € 35,384 profit.

Paid out € 91,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR DE SELYS LONGCHAMPS , PEDIATRE? We notify you, reason included.

Follow DR DE SELYS LONGCHAMPS , PEDIATRE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jean Michel Ariel Baron de SELYS LONGCHAMPS

DR DE SELYS LONGCHAMPS , PEDIATRE

HARIBA 8%

Behind DR DE SELYS LONGCHAMPS , PEDIATRE is Jean Michel Ariel Baron de SELYS LONGCHAMPS. It owns 8% of HARIBA itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Jean Michel Ariel Baron de SELYS LONGCHAMPS

Administrator-manager

since 2006

Establishments

Establishment units

Physical locations of this company

Registered office

Dodonéestraat 82

1180 Ukkel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0880.077.040
VAT number: BE 0880.077.040
Registered office: Dodonéestraat 82, 1180 Ukkel
Names & denominations: DR DE SELYS LONGCHAMPS , PEDIATRE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 March 2006
Peppol: Active · Active since 27 Jan 2026

View on CBE Public ↗ Annual accounts (NBB) ↗